Disc Medicine (IRON) News Today $50.08 +0.39 (+0.78%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRON Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period D. E. Shaw & Co. Inc. Acquires Shares of 81,190 Disc Medicine, Inc. (NASDAQ:IRON)D. E. Shaw & Co. Inc. bought a new position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 81,190 shares of the company's stock, valued at approMay 19 at 4:13 AM | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Northern Trust CorpNorthern Trust Corp boosted its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 9.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 187,017 shares of the company's stock after purchasingMay 19 at 3:17 AM | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) is MPM Bioimpact LLC's 7th Largest PositionMPM Bioimpact LLC increased its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 11.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 346,401 shares of the company's stock after acquiring an additional 34,640 shares during theMay 16, 2025 | marketbeat.com56,400 Shares in Disc Medicine, Inc. (NASDAQ:IRON) Bought by Patient Square Capital LPPatient Square Capital LP bought a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 56,400 shares of the company's stock, valued at approximately $3,576,000May 16, 2025 | marketbeat.comCubist Systematic Strategies LLC Makes New Investment in Disc Medicine, Inc. (NASDAQ:IRON)Cubist Systematic Strategies LLC purchased a new position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 20,187 shares of the company's stock, valuedMay 16, 2025 | marketbeat.comJanus Henderson Group PLC Grows Stock Position in Disc Medicine, Inc. (NASDAQ:IRON)Janus Henderson Group PLC increased its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 62.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,217,815 shares of the company's stock after buying an additional 467,9May 15, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Price Target Raised to $120.00BMO Capital Markets upped their target price on shares of Disc Medicine from $112.00 to $120.00 and gave the stock an "outperform" rating in a research note on Monday.May 14, 2025 | marketbeat.comDisc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 CongressMay 14, 2025 | globenewswire.comDisc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor ConferenceMay 14, 2025 | finance.yahoo.comDisc Medicine FY2029 EPS Forecast Lowered by HC WainwrightDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Research analysts at HC Wainwright dropped their FY2029 earnings per share estimates for shares of Disc Medicine in a research report issued on Thursday, May 8th. HC Wainwright analyst D. Tsao now anticipates that the company will post earnings peMay 14, 2025 | marketbeat.comFred Alger Management LLC Purchases New Position in Disc Medicine, Inc. (NASDAQ:IRON)Fred Alger Management LLC acquired a new position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 11,775 shares of the company's stock, valued at approximately $747,000. OtMay 13, 2025 | marketbeat.comBrevan Howard Capital Management LP Makes New $394,000 Investment in Disc Medicine, Inc. (NASDAQ:IRON)Brevan Howard Capital Management LP bought a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 6,213 shares of the company's stock,May 13, 2025 | marketbeat.comAlgert Global LLC Buys 9,397 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Algert Global LLC lifted its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 135.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,337 shares of the company's stock aftMay 13, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company raised its position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 32.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 38,459 shares of the company's stock after purchasing an additional 9,394 shares duriMay 13, 2025 | marketbeat.comFY2025 EPS Estimates for Disc Medicine Reduced by AnalystMay 13, 2025 | americanbankingnews.comCantor Fitzgerald Comments on Disc Medicine FY2025 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Disc Medicine in a research report issued on Thursday, May 8th. Cantor Fitzgerald analyst K. Kluska now expects that the company will post earnings of (May 13, 2025 | marketbeat.comQ2 EPS Estimates for Disc Medicine Cut by Leerink PartnrsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Analysts at Leerink Partnrs decreased their Q2 2025 EPS estimates for Disc Medicine in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings per share of ($1.20) for theMay 13, 2025 | marketbeat.comQ2 EPS Estimates for Disc Medicine Lowered by AnalystMay 13, 2025 | americanbankingnews.comDisc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by Dimensional Fund Advisors LPDimensional Fund Advisors LP grew its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 160.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 139,720 shares of the company's stock after purchasiMay 12, 2025 | marketbeat.comWedbush Has Negative Forecast for Disc Medicine Q2 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Equities researchers at Wedbush dropped their Q2 2025 earnings per share (EPS) estimates for shares of Disc Medicine in a research report issued to clients and investors on Wednesday, May 7th. Wedbush analyst D. Nierengarten now expects that the cMay 11, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of "Buy" by AnalystsDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has earned a consensus rating of "Buy" from the eleven analysts that are currently covering the stock, Marketbeat reports. Ten analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the companyMay 11, 2025 | marketbeat.comWedbush Issues Negative Estimate for Disc Medicine EarningsMay 11, 2025 | americanbankingnews.comDeerfield Management Company L.P. Series C Lowers Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON)Deerfield Management Company L.P. Series C reduced its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 41.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 600,515 shares of the company's stock after selling 422May 10, 2025 | marketbeat.comTudor Investment Corp ET AL Makes New $847,000 Investment in Disc Medicine, Inc. (NASDAQ:IRON)Tudor Investment Corp ET AL bought a new stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 13,353 shares of the company's stock, valued at approximatelMay 9, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Insider Sells 2,100 Shares of StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) insider William Jacob Savage sold 2,100 shares of Disc Medicine stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $50.17, for a total transaction of $105,357.00. Following the transaction, the insider now owns 66,398 shares of the company's stock, valued at $3,331,187.66. The trade was a 3.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.May 9, 2025 | marketbeat.comWilliam Jacob Savage Sells 2,100 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockMay 8, 2025 | insidertrades.comDisc Medicine Inc: Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 7, 2025 | finanznachrichten.deDisc Medicine (NASDAQ:IRON) Shares Gap Down - Should You Sell?Disc Medicine (NASDAQ:IRON) Shares Gap Down - Here's What HappenedMay 7, 2025 | marketbeat.comDisc Medicine Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 7, 2025 | globenewswire.comBaker BROS. Advisors LP Takes Position in Disc Medicine, Inc. (NASDAQ:IRON)Baker BROS. Advisors LP acquired a new position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 77,050 shares of the company's stock, valued atMay 6, 2025 | marketbeat.comInvesco Ltd. Increases Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON)Invesco Ltd. increased its stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 93.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,881 shares of the company's stock after buying anMay 5, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Reaches New 1-Year High - What's Next?Disc Medicine (NASDAQ:IRON) Sets New 52-Week High - Here's What HappenedMay 3, 2025 | marketbeat.comDisc Medicine (IRON) to Release Earnings on ThursdayDisc Medicine (NASDAQ:IRON) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-disc-medicine-inc-stock/)May 3, 2025 | marketbeat.comPDT Partners LLC Invests $1.63 Million in Disc Medicine, Inc. (NASDAQ:IRON)PDT Partners LLC bought a new stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 25,778 shares of the company's stock, valued at approximately $1,634,000. PDT Partners LMay 2, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Acquires 262,690 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Price T Rowe Associates Inc. MD increased its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 23.2% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 1,394,637 shares of the company's stock after buying an additional 262,690 shareApril 30, 2025 | marketbeat.comWells Fargo & Company MN Grows Position in Disc Medicine, Inc. (NASDAQ:IRON)Wells Fargo & Company MN lifted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 60.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 20,778 shares of the company's stock after purchasApril 30, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 200,000 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Adage Capital Partners GP L.L.C. lessened its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 36.4% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 350,000 shares of the company's stock after selling 200,000 shApril 29, 2025 | marketbeat.comRaymond James Financial Inc. Makes New Investment in Disc Medicine, Inc. (NASDAQ:IRON)Raymond James Financial Inc. acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 88,002 shares of the company's stock, valued at approximatelApril 27, 2025 | marketbeat.comBlue Owl Capital Holdings LP Has $7.62 Million Holdings in Disc Medicine, Inc. (NASDAQ:IRON)Blue Owl Capital Holdings LP decreased its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 31.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 120,260 shares of the company's sApril 26, 2025 | marketbeat.comJump Financial LLC Buys Shares of 11,507 Disc Medicine, Inc. (NASDAQ:IRON)Jump Financial LLC purchased a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 11,507 shares of the company's stock, valued at approximately $730,000. SApril 25, 2025 | marketbeat.comSilverarc Capital Management LLC Acquires 6,519 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Silverarc Capital Management LLC grew its holdings in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 6.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 110,381 shares of the company's stock after buyinApril 24, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) is Bain Capital Life Sciences Investors LLC's 4th Largest PositionBain Capital Life Sciences Investors LLC decreased its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 45.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 983,500 shares of the company's stock after selliApril 23, 2025 | marketbeat.comWalleye Capital LLC Sells 182,232 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Walleye Capital LLC lowered its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 87.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,004 shares of the company's stock after sApril 22, 2025 | marketbeat.comRenaissance Technologies LLC Makes New $5.48 Million Investment in Disc Medicine, Inc. (NASDAQ:IRON)Renaissance Technologies LLC purchased a new stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 86,420 shares of the company's stock, valued at approximately $5,479,000. Renaissance TechnologieApril 22, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 44,762 Shares of Disc Medicine, Inc. (NASDAQ:IRON)JPMorgan Chase & Co. raised its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 275.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 61,017 shares of the company's stock afteApril 22, 2025 | marketbeat.comFmr LLC Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON)Fmr LLC grew its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 358.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,866,248 shares of the company's stock after purchasing an aApril 16, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of "Buy" by BrokeragesDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has been assigned an average rating of "Buy" from the eleven ratings firms that are presently covering the firm, MarketBeat reports. Ten research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendatioApril 15, 2025 | marketbeat.comVanguard Group Inc. Has $67.73 Million Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON)Vanguard Group Inc. increased its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,068,246 shares of the company's stock after acquiring an aApril 13, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Trading Down 7.3% - What's Next?Disc Medicine (NASDAQ:IRON) Trading Down 7.3% - What's Next?April 10, 2025 | marketbeat.comADAR1 Capital Management LLC Decreases Position in Disc Medicine, Inc. (NASDAQ:IRON)ADAR1 Capital Management LLC decreased its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 81.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,196 shares of the company's stoApril 10, 2025 | marketbeat.com Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address IRON Media Mentions By Week IRON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRON News Sentiment▼0.650.65▲Average Medical News Sentiment IRON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRON Articles This Week▼85▲IRON Articles Average Week Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Elanco Animal Health News Legend Biotech News TG Therapeutics News Telix Pharmaceuticals Limited American Depositary Shares News Verona Pharma News Lantheus News Axsome Therapeutics News Grifols News Nuvalent News ADMA Biologics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRON) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IRON Stock Free IRON Stock Alerts